Expression of Programmed Cell Death 1 and Helios Genes Correlates With rs872071A>G and rs12203592C>T Single-Nucleotide Polymorphisms of InterferonRegulatory Factor 4 in Patients with T-Cell-Mediated Rejection of Renal Allograft [0.03%]
程序性死亡配体1和Helios基因的表达与肾移植患者T细胞介导排斥反应中干扰素调控因子4的rs872071A>G和rs12203592C>T单核苷酸多态性相关性研究
Azam Alamdari,Farzaneh Sadat Minoo,Sara Assadiasl et al.
Azam Alamdari et al.
Objectives: Acute T-cell-mediated rejection of the renal allograft is a serious posttransplant challenge that requires administration of high-dose immunosuppressive drugs with considerable side effects; therefore, specifi...
Maria Irene Bellini,Augusto Lauro,Vito D&#x;Andrea et al.
Maria Irene Bellini et al.
Management of benign liver tumors represents still an open debate, with no clear guidelines for patient selection,treatment options, and indications to surgical intervention. Usually, most of these diseases are conservatively treated, in vi...
T-Cell-Positive, B-Cell-Negative Flow Cytometry Crossmatch: Frequency, HLA Locus Specificity, and Mechanisms Among 3073 Clinical Flow Cytometry Crossmatch Tests [0.03%]
3073例临床流动免疫荧光交叉配型中T细胞阳性B细胞阴性结果的频率、HLA特异性和机制分析
Prabhakar Putheti,Vijay K Sharma,Rex Friedlander et al.
Prabhakar Putheti et al.
Objectives: A T-cell-positive and B-cell-negative flow cytometry crossmatch result remains a conundrum since HLA class I antigens are expressed on both T and B cells. We investigated the frequency, donor HLA specificity o...
Muhammet Ali Beyoglu,Mehmet Furkan Sahin,Sinan Turkkan et al.
Muhammet Ali Beyoglu et al.
Objectives: In this study, we investigated dynamic thiol-disulfide homeostasis as a new indicator of oxidative stress in lung transplant recipients. In addition, we compared dynamic thiol-disulfide homeostasis parameters ...
Favipiravir Use in Kidney Transplant Recipients with COVID-19: A Single-Center Experience [0.03%]
肾移植受者COVID-19 Favipiravir使用经验报告
Burcu Kaya,Dilek Barutcu Atas,Elif Tukenmez Tigen et al.
Burcu Kaya et al.
Objectives: Kidney transplant recipients are among the high-risk groups for severe COVID-19. To date, no specific antiviral agent has proved uniformly effective against SARS-CoV-2. Favipiravir, the recommended drug by the...
COVID-19-Related Rhino-Orbital-Cerebral Mucormycosis in a Renal Transplant Recipient [0.03%]
肾移植受者新冠肺炎相关的Rhino-orbital-cerebral念珠菌病病例报告
Şerife Gökbulut Bektaş,Ahmet Bilal Kandemir,Çağlayan Merve Ayaz et al.
Şerife Gökbulut Bektaş et al.
Coronavirus disease 2019 increases transplant recipients' susceptibility to rare opportunistic infections as a consequence of the impairment that COVID-19 can cause in the immune system. Mucormycosis is a rare complication but has a high ri...
Plasma Cell-Free DNA as a Novel Method for Early Detection of Acute Rejection in Uterine Transplant [0.03%]
胎盘细胞游离DNA在子宫移植急性排斥反应早期诊断中的应用价值探讨
Alireza Hamidian Jahromi,Sydney R Horen,Liza Johannesson
Alireza Hamidian Jahromi
Anti-Interleukin 6 Therapeutics for Chronic Antibody-Mediated Rejection In Kidney Transplant Recipients [0.03%]
肾移植受者的慢性抗体介导性排斥反应的抗白细胞介素-6治疗
Rajeev Sharma
Rajeev Sharma
Chronic antibody-mediated rejection is the predominant cause for late renal allograft loss for which there is, as yet, no treatment approved by the US Food and Drug Administration, although there are clinical trials in progress to evaluate ...
Liver Transplant in Hemoglobin SC Disease and Autoimmune Hepatitis: A Case Report [0.03%]
肝SC病和自身免疫性肝炎患者的肝脏移植一例报告
Ahyoung Kim,Naziheh Assarzadegan,Robert A Anders et al.
Ahyoung Kim et al.
Although liver transplant is a life-saving measure for individuals with end-stage liver disease, the perioperative management may be challenging in individuals with concomitant sickle cell disease. We report a case of a 50-year-old man with...
Complete Recovery After Immunosuppressive Treatment Change in a Patient With Posttransplant Lymphoproliferative Disorder [0.03%]
免疫抑制治疗后移植后淋巴增殖性疾病患者的完全缓解病例报告
Derya Arı,Dilara Turan,Hale Gökcan et al.
Derya Arı et al.
Posttransplant lymphoproliferative diseases are a rare but important cause of morbidity and mortality secondary to immunosuppression after solid-organ or bone marrow transplant. Generally, posttransplant lymphoproliferative diseases develop...